While the company is showing early signs of recovery and margin improvement, a high valuation means risks remain.

Tariffs on medical supplies are causing delays, wait times, and increased costs for hospitals, and the president’s tariffs ...

GenAI is changing pharma operations. Explore real-world tools and use cases for AI in pharmaceutical industry workflows.

We believe the top-line growth for AST will reach 10% as new plants in Illinois, California, and New York ramp up production. Given the current scale of Steris’ AST operations (close to $1 billion in ...

In regulated industries like life sciences, quality and manufacturing have traditionally been built for assurance, not ...

That's great news for Nvidia and other frontline players in the AI/data center industry. It's also great news for some of the ...

Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a ...

How Dynamic Risk Management Can Turn Chaos Into Opportunity. Forrester. The recent introduction of US-imposed tariffs has ...

Aizon and Sequence are pleased to announce a new strategic partnership aimed at delivering comprehensive, AI-powered ...

Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary. Read why TMO stock is a ...

The scale-up of mechanochemical methods could play a transformative role in making manufacturing processes in the pharmaceutical industry greener by eliminating solvent use and recovery. Combined with ...